Literature DB >> 13511136

Study of antirabies immunization of man; observations with HEP Flury and other vaccines, with and without hyperimmune serum, in primary and recall immunizations.

J P FOX, H KOPROWSKI, D P CONWELL, J BLACK, H M GELFAND.   

Abstract

Detailed results are presented of primary immunizations of 387 persons with various courses of HEP Flury vaccine and of 54 persons with Harris- or Semple-type vaccines. Antibody response to HEP Flury vaccine was at least as rapid as that to the conventional type, but fell short in uniformity and level of response. The most promising course involved a 4-dose schedule, intradermal alone or combined with intramuscular, at 5-day intervals. A similar subcutaneous course of Semple vaccine yielded results completely equivalent to those of a 14-dose course of Harris vaccine. It is concluded that, although living, the HEP Flury virus does not multiply in man and that its lesser antigenic potency, as compared with Semple or Harris vaccines, is due to its relatively small content of viral antigen.Further evidence has been obtained that hyperimmune serum may exert a slight suppressive effect on active response, but the opinion is expressed that, with vaccines of full potency, this will not be of practical significance.Restimulation of immunity by a booster dose of HEP Flury vaccine was studied in 64 experimentally immunized persons and in 136 persons with history of previous Pasteur treatment. In both instances small intradermal inocula were as effective as larger intramuscular inocula in recalling pre-existing immunity.Study of recipients of Pasteur treatment indicated that antibody commonly persists for at least 5 years after a single course and for 15 or more years after re-treatment. It was also observed that the ability to respond to a booster of HEP Flury vaccine persists for at least 25 years. The response elicited by the booster is prompt and is usually at least equal to that resulting from a full primary course. The suggested conclusion is that previously treated persons need not receive more than a single booster on re-exposure, and that Pasteur treatment provides a solid basis for long-sustained immunity.

Entities:  

Keywords:  RABIES/immunology

Mesh:

Substances:

Year:  1957        PMID: 13511136      PMCID: PMC2537639     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Infection of the one-day old fertile hen's egg with rabies virus. I. Growth curves and serial passages.

Authors:  K YOSHINO; N KUMA; A KONDO; M KITAOKA
Journal:  Jpn J Med Sci Biol       Date:  1956-12

2.  Anti-rabies vaccination of man with HEP Flury virus.

Authors:  D P CONWELL; J P FOX; P GERHARDT
Journal:  Bull Tulane Univ Med Fac       Date:  1956-11

3.  [Field trials with rabies vaccine on persons bitten by rabid wolves].

Authors:  M BALTAZARD; M BAHMANYAR
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

4.  Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf.

Authors:  K HABEL; H KOPROWSKI
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

5.  Studies on chick-embryo-adapted-rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo.

Authors:  H KOPROWSKI; J BLACK; D J NELSEN
Journal:  J Immunol       Date:  1954-01       Impact factor: 5.422

6.  Pathogenesis of poliomyelitis.

Authors:  D BODIAN
Journal:  Am J Public Health Nations Health       Date:  1952-11

7.  Rabies vaccine encephalomyelitis in relation to the incidence of animal rabies in Los Angeles.

Authors:  C F PAIT; H E PEARSON
Journal:  Am J Public Health Nations Health       Date:  1949-07

8.  Studies on chick embryo adapted rabies virus. III. Duration of immunity in vaccinated dogs.

Authors:  H KOPROWSKI; J BLACK
Journal:  Proc Soc Exp Biol Med       Date:  1952-07

9.  Studies on chick-embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes.

Authors:  H KOPROWSKI; J BLACK
Journal:  J Immunol       Date:  1950-03       Impact factor: 5.422

10.  Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).

Authors:  C G CULBERTSON; F B PECK; H M POWELL
Journal:  J Am Med Assoc       Date:  1956-12-08
View more
  11 in total

1.  INFECTION OF THE ONE-DAY OLD FERTILE HEN'S EGG WITH RABIES VIRUS. VIII. BETA-PROPIOLACTONE INACTIVATED VACCINE PRODUCED BY INOCULATION OF ONE-DAY EGGS WITH NISHIGAHARA-O30-M (NOPM) STRAIN.

Authors:  K YOSHINO; K SAITO
Journal:  Arch Gesamte Virusforsch       Date:  1963-08-26

2.  [On the problem of central nervous complications following rabies vaccination].

Authors:  K JELLINGER; F SEITELBERGER
Journal:  Dtsch Z Nervenheilkd       Date:  1963

3.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3.

Authors:  P ATANASIU; D A CANNON; D J DEAN; J P FOX; K HABEL; M M KAPLAN; R E KISSLING; H KOPROWSKI; P LEPINE; F PEREZ GALLARDO
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

4.  Infection of the one-day old fertile hen's egg with rabies virus. VII. Comparison of viral yields obtained by inoculation of eggs of different ages with different strains and production of vaccine.

Authors:  K YOSHINO; M SUZUKI; A KONDO
Journal:  Arch Gesamte Virusforsch       Date:  1961

5.  Primary antirabies immunization of man with HEP flury virus vaccine.

Authors:  J M RUEGSEGGER; J BLACK; G R SHARPLESS
Journal:  Am J Public Health Nations Health       Date:  1961-05

6.  History of vaccination.

Authors:  Stanley Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

7.  Human pre-exposure rabies immunization with suckling mouse brain vaccine.

Authors:  E Fuenzalida
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

Review 8.  Rabies. Suggested indications for treatment of exposed persons.

Authors:  G L Humphrey
Journal:  Calif Med       Date:  1967-11

Review 9.  The vaccination of man and other animals against rabies.

Authors:  J Crick
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

10.  ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.

Authors:  E FUENZALIDA; R PALACIOS; J M BORGONO
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.